Folgen
Mark M Bailey, PhD
Mark M Bailey, PhD
National Intelligence University (NIU)
Bestätigte E-Mail-Adresse bei mail.mil
Titel
Zitiert von
Zitiert von
Jahr
Nanoparticle formulations in pulmonary drug delivery
MM Bailey, CJ Berkland
Medicinal research reviews 29 (1), 196-212, 2009
3632009
A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage
MM Bailey, L Wang, CJ Bode, KE Mitchell, MS Detamore
Tissue engineering 13 (8), 2003-2010, 2007
2072007
Pure insulin nanoparticle agglomerates for pulmonary delivery
MM Bailey, EM Gorman, EJ Munson, C Berkland
Langmuir 24 (23), 13614-13620, 2008
682008
Nanocluster compositions and methods
CJ Berkland, L Shi, N El Gendy, C Plumley, M Bailey
US Patent 8,906,392, 2014
552014
Fluorinated copolymer nanoparticles for multimodal imaging applications
MM Bailey, CM Mahoney, KE Dempah, JM Davis, ML Becker, S Khondee, ...
Macromolecular rapid communications 31 (1), 87-92, 2010
222010
Functionalized, carbon nanotube material for the catalytic degradation of organophosphate nerve agents
MM Bailey, JM Heddleston, J Davis, JL Staymates, AR Hight Walker
Nano Research 7, 390-398, 2014
202014
Particle engineering technologies for pulmonary drug delivery
N El-Gendy, MM Bailey, C Berkland
Controlled pulmonary drug delivery, 283-312, 2011
142011
Fluorinated polymers and associated methods
C Berkland, M Bailey
US Patent App. 12/883,943, 2011
132011
Formulation and Characterization of NanoCluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis
S Ruiz, N El-Gendy, L Bowen, C Berkland, M Bailey
Respiratory Drug Delivery 2016 Meeting, 2016
102016
Chemically modifiable fluorinated copolymer nanoparticles for 19F‐MRI contrast enhancement
MM Bailey, SR Kline, MD Anderson, JL Staymates, C Berkland
Journal of applied polymer science 126 (4), 1218-1227, 2012
102012
Pulmonary delivery of ceftazidime for the treatment of melioidosis in a murine model
SI Ruiz, LE Bowen, MM Bailey, C Berkland
Molecular pharmaceutics 15 (3), 1371-1376, 2018
62018
Examining the differential risk from high-level artificial intelligence and the question of control
KA Kilian, CJ Ventura, MM Bailey
Futures 151, 103182, 2023
52023
An International Consortium for Evaluations of Societal-Scale Risks from Advanced AI
R Gruetzemacher, A Chan, K Frazier, C Manning, Š Los, J Fox, ...
arXiv preprint arXiv:2310.14455, 2023
22023
A hypergraph-based machine learning ensemble network intrusion detection system
ZZ Lin, TD Pike, MM Bailey, ND Bastian
arXiv preprint arXiv:2211.03933, 2022
22022
PERSPECTIVE: Why Strong Artificial Intelligence Weapons Should Be Considered WMD
M Bailey
https://www.hstoday.us/subject-matter-areas/infrastructure-security …, 2021
22021
Detecting Propagators of Disinformation on Twitter Using Quantitative Discursive Analysis
MM Bailey
Journal of Intelligence Community Research and Development 1 (3), 2020
22020
Development and characterization of an oro-nasal inhalation plethysmography mask exposure system
LE Bowen, MM Bailey, BR Haupt, JB Anderson
Aerosol Science and Technology 51 (4), 509-517, 2017
12017
15 Modified Release Delivery Systems
MM Bailey, CJ Berkland
Biodrug Delivery Systems: Fundamentals, Applications and Clinical …, 2016
1*2016
The Necessity of AI Audit Standards Boards
D Manheim, S Martin, M Bailey, M Samin, R Greutzmacher
arXiv preprint arXiv:2404.13060, 2024
2024
RESEARCH SHORT
MM Bailey
2023
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20